| 000 | 01701 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517024940.0 | ||
| 264 | 0 | _c20160725 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1462-2920 | ||
| 024 | 7 |
_a10.1111/1462-2920.12873 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKwan, Brian W | |
| 245 | 0 | 0 |
_aCombatting bacterial infections by killing persister cells with mitomycin C. _h[electronic resource] |
| 260 |
_bEnvironmental microbiology _cNov 2015 |
||
| 300 |
_a4406-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAmpicillin _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBiofilms _xgrowth & development |
| 650 | 0 | 4 |
_aCaenorhabditis elegans _xdrug effects |
| 650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
| 650 | 0 | 4 |
_aCross-Linking Reagents _xpharmacology |
| 650 | 0 | 4 |
_aCystic Fibrosis _xmicrobiology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Resistance, Multiple, Bacterial |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
| 650 | 0 | 4 |
_aEscherichia coli K12 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitomycin _xpharmacology |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 700 | 1 | _aChowdhury, Nityananda | |
| 700 | 1 | _aWood, Thomas K | |
| 773 | 0 |
_tEnvironmental microbiology _gvol. 17 _gno. 11 _gp. 4406-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/1462-2920.12873 _zAvailable from publisher's website |
| 999 |
_c24789909 _d24789909 |
||